Your browser doesn't support javascript.
loading
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial.
Del Mastro, Lucia; Poggio, Francesca; Blondeaux, Eva; De Placido, Sabino; Giuliano, Mario; Forestieri, Valeria; De Laurentiis, Michelino; Gravina, Adriano; Bisagni, Giancarlo; Rimanti, Anita; Turletti, Anna; Nisticò, Cecilia; Vaccaro, Angela; Cognetti, Francesco; Fabi, Alessandra; Gasparro, Simona; Garrone, Ornella; Alicicco, Maria Grazia; Urracci, Ylenia; Mansutti, Mauro; Poletti, Paola; Correale, Pierpaolo; Bighin, Claudia; Puglisi, Fabio; Montemurro, Filippo; Colantuoni, Giuseppe; Lambertini, Matteo; Boni, Luca.
Affiliation
  • Del Mastro L; Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Genova, Italy. Electronic address: lucia.delmastro@hsanmartino.it.
  • Poggio F; Department of Medical Oncology, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Blondeaux E; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • De Placido S; Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
  • Giuliano M; Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
  • Forestieri V; Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
  • De Laurentiis M; Division of Breast Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione G Pascale, Napoli, Italy.
  • Gravina A; Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G Pascale, Napoli, Italy.
  • Bisagni G; Oncology Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Rimanti A; Department of Oncology, ASST Mantova, AO Carlo Poma, Mantova, Italy.
  • Turletti A; Breast Unit, ASL Citta' di Torino, Torino, Italy.
  • Nisticò C; Medical Oncology Unit, ASL Frosinone, Frosinone, Italy.
  • Vaccaro A; Medical Oncology Unit, ASL Frosinone, Frosinone, Italy.
  • Cognetti F; Division of Medical Oncology 1, Regina Elena National Cancer Institute, Roma, Italy.
  • Fabi A; Unit of Precision Medicine in Breast Cancer, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Roma, Italy.
  • Gasparro S; Division of Medical Oncology 1, Regina Elena National Cancer Institute, Roma, Italy.
  • Garrone O; Department of Oncology, Ospedale di Insegnamento S Croce e Carle, Cuneo, Italy; Medical Oncology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Milan, Italy.
  • Alicicco MG; Department of Oncology, UOC Oncologia, Azienda Ospedaliera Universitaria, Sassari, Italy.
  • Urracci Y; Department of Medical Oncology, Hospital Businco, Cagliari, Italy.
  • Mansutti M; Department of Oncology, ASUFC Santa Maria Della Misericordia, Udine, Italy.
  • Poletti P; Department of Medical Oncology, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Correale P; Medical Oncology Unit, Grand Metropolitan Hospital "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
  • Bighin C; Department of Medical Oncology, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Puglisi F; Department of Medicine, University of Udine, Udine, Italy; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano, IRCCS, Aviano, Italy.
  • Montemurro F; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
  • Colantuoni G; Medical Oncology, Azienda Ospedaliera S Giuseppe Moscati, Avellino, Italy.
  • Lambertini M; Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Genova, Italy.
  • Boni L; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Lancet Oncol ; 23(12): 1571-1582, 2022 12.
Article in En | MEDLINE | ID: mdl-36370716
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article